0001140361-26-005130
SEC filingNu Skin Enterprises, Inc. reported fiscal year 2025 results with revenue of $1.49 billion, generating net income of $160.2 million. The company's performance was significantly impacted by a $176.2 million gain on sale of business, which contributed substantially to the pre-tax income of $196.2 million. Operating income was $65.8 million, reflecting operating expenses of $965.6 million against gross profit of $1.03 billion. The company maintained a strong balance sheet with total assets of $1.41 billion, total liabilities of $600.1 million, and stockholders' equity of $805.2 million. Cash flow from operations was $80.3 million, while investing activities generated $170.7 million primarily from business sale proceeds. The company ended the period with $264.7 million in cash and cash equivalents. No prior year comparative figures are provided in the source data for year-over-year analysis.
Nu Skin Enterprises, Inc. reported fiscal year 2025 financial results with revenue of $1.49 billion and net income of $160.2 million. The company generated gross profit of $1.03 billion from cost of sales of $453.8 million, resulting in a gross margin of 69.1%. Operating income was $65.8 million after total operating expenses of $965.6 million, which included selling expenses of $508.4 million, general and administrative expenses of $432.1 million, and restructuring and impairment expenses of $25.1 million. The income before provision for income taxes was $196.2 million, significantly boosted by a $176.2 million gain on sale of business. The company reported basic and diluted earnings per share of $3.00, based on 49.3 million basic weighted-average common shares outstanding and 50.3 million diluted shares.
The source data provides consolidated revenue of $1.49 billion for fiscal year 2025 but does not disclose segment breakdown, geographic mix, or specific growth drivers. The document content and XBRL data focus on consolidated financial statements without segment-level detail. Revenue generation appears to be supported by the company's core operations, though the significant gain on sale of business ($176.2 million) indicates strategic asset dispositions during the period. No comparative prior year revenue figures are provided in the source data for growth rate analysis.
The company achieved a gross margin of 69.1% for fiscal year 2025, calculated from gross profit of $1.03 billion on revenue of $1.49 billion. Operating margin was 4.4%, derived from operating income of $65.8 million. The cost structure shows selling expenses representing 34.1% of revenue ($508.4 million) and general and administrative expenses representing 29.0% of revenue ($432.1 million). Restructuring and impairment expenses accounted for 1.7% of revenue ($25.1 million). The net income margin was 10.8%, calculated from net income of $160.2 million. The gain on sale of business significantly impacted profitability metrics, contributing 11.8% of revenue.
Operating activities generated $80.3 million in cash flow, starting from net income of $160.2 million and adjusting for non-cash items including a $176.2 million gain on sale (subtracted), $52.3 million depreciation and amortization, $26.2 million non-cash lease expense, and $24.1 million stock-based compensation. Investing activities provided $170.7 million, primarily from $193.7 million proceeds from sale of business net, partially offset by $34.3 million purchases of property and equipment. Financing activities used $202.4 million, mainly from $225.0 million payments on debt, $20.0 million share repurchases, and $11.8 million dividend payments. The balance sheet shows total assets of $1.41 billion, including $547.7 million current assets with $264.7 million cash. Total liabilities were $600.1 million, including $224.2 million total debt. Stockholders' equity was $805.2 million.
The source data does not contain management guidance, strategic priorities, or specific risk factor disclosures beyond the financial statements. The filing presents historical financial results for fiscal year 2025 without forward-looking statements or outlook commentary. The financial statements indicate ongoing operations with restructuring activities ($25.1 million expense) and significant asset dispositions ($176.2 million gain on sale). The company maintained dividend payments ($11.8 million) and share repurchases ($20.0 million) while reducing debt ($225.0 million payments against $55.0 million proceeds). No specific guidance on future performance, market conditions, or strategic initiatives is provided in the available data.